- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.96 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x VZR: 4-methyl-7-[[1-[(3-oxidanyl-4-phenoxy-phenyl)methyl]-1,2,3-triazol-4-yl]methoxy]chromen-2-one(Non-covalent)
VZR.2: 21 residues within 4Å:- Chain A: G.99, F.100, M.101, M.106, F.152, M.158, P.159, A.160, Y.161, M.164, K.168, A.201, M.202, I.205, V.206, Q.217, I.218, L.220, L.221
- Chain B: L.271
- Ligands: NAD.1
12 PLIP interactions:11 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:M.101, A:F.152, A:M.158, A:Y.161, A:A.201, A:I.205, A:I.205, A:L.221, B:L.271
- Hydrogen bonds: A:Y.161, A:Y.161, A:Q.217
VZR.4: 21 residues within 4Å:- Chain A: L.271, L.272
- Chain B: G.99, F.100, M.101, M.106, F.152, M.158, P.159, A.160, Y.161, M.164, A.201, M.202, I.205, V.206, Q.217, L.220, L.221, R.228
- Ligands: NAD.3
11 PLIP interactions:9 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:F.152, B:Y.161, B:A.201, B:I.205, B:I.205, B:L.221, A:L.271, A:L.272
- Hydrogen bonds: B:Y.161, B:Y.161
- pi-Stacking: B:F.152
VZR.6: 20 residues within 4Å:- Chain C: G.99, F.100, M.101, M.106, F.152, M.158, P.159, A.160, Y.161, M.164, K.168, A.201, M.202, I.205, V.206, Q.217, L.220, L.221
- Chain D: L.272
- Ligands: NAD.5
10 PLIP interactions:9 interactions with chain C, 1 interactions with chain D- Hydrophobic interactions: C:P.159, C:Y.161, C:A.201, C:M.202, C:I.205, C:I.205, C:L.221, D:L.272
- Hydrogen bonds: C:Y.161
- pi-Stacking: C:F.152
VZR.8: 21 residues within 4Å:- Chain C: L.271, L.272
- Chain D: G.99, F.100, M.101, M.106, F.152, M.158, P.159, A.160, Y.161, M.164, K.168, A.201, M.202, I.205, V.206, Q.217, L.220, L.221
- Ligands: NAD.7
10 PLIP interactions:8 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: D:Y.161, D:A.201, D:M.202, D:I.205, D:I.205, D:L.221, C:L.271, C:L.272
- Hydrogen bonds: D:Y.161
- pi-Stacking: D:F.152
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chebaiki, M. et al., Discovery of new diaryl ether inhibitors against Mycobacterium tuberculosis targeting the minor portal of InhA. Eur.J.Med.Chem. (2023)
- Release Date
- 2023-08-16
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.96 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x VZR: 4-methyl-7-[[1-[(3-oxidanyl-4-phenoxy-phenyl)methyl]-1,2,3-triazol-4-yl]methoxy]chromen-2-one(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chebaiki, M. et al., Discovery of new diaryl ether inhibitors against Mycobacterium tuberculosis targeting the minor portal of InhA. Eur.J.Med.Chem. (2023)
- Release Date
- 2023-08-16
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D